Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

RVLP

RVL Pharmaceuticals (RVLP)

RVL Pharmaceuticals PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RVLP
DateTimeSourceHeadlineSymbolCompany
18/01/202408:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVLPRVL Pharmaceuticals PLC
21/12/202308:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVLPRVL Pharmaceuticals PLC
27/11/202322:50GlobeNewswire Inc.RVL Completes Financial RestructuringNASDAQ:RVLPRVL Pharmaceuticals PLC
17/11/202301:11Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:RVLPRVL Pharmaceuticals PLC
02/11/202307:27Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:RVLPRVL Pharmaceuticals PLC
24/10/202307:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVLPRVL Pharmaceuticals PLC
24/10/202304:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVLPRVL Pharmaceuticals PLC
21/10/202308:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVLPRVL Pharmaceuticals PLC
21/10/202306:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVLPRVL Pharmaceuticals PLC
21/10/202304:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVLPRVL Pharmaceuticals PLC
19/10/202307:00Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RVLPRVL Pharmaceuticals PLC
14/10/202308:28Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:RVLPRVL Pharmaceuticals PLC
14/10/202307:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVLPRVL Pharmaceuticals PLC
12/10/202321:50GlobeNewswire Inc.RVL Pharmaceuticals plc Announces Prepackaged Reorganization of Certain U.S. SubsidiariesNASDAQ:RVLPRVL Pharmaceuticals PLC
30/09/202306:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVLPRVL Pharmaceuticals PLC
23/09/202306:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVLPRVL Pharmaceuticals PLC
06/09/202306:18Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:RVLPRVL Pharmaceuticals PLC
06/09/202306:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVLPRVL Pharmaceuticals PLC
05/09/202321:45Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:RVLPRVL Pharmaceuticals PLC
01/09/202304:23Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:RVLPRVL Pharmaceuticals PLC
30/08/202314:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RVLPRVL Pharmaceuticals PLC
26/08/202307:21Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:RVLPRVL Pharmaceuticals PLC
26/08/202306:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVLPRVL Pharmaceuticals PLC
24/08/202307:30Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:RVLPRVL Pharmaceuticals PLC
24/08/202306:05GlobeNewswire Inc.RVL Pharmaceuticals plc to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:RVLPRVL Pharmaceuticals PLC
19/08/202306:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVLPRVL Pharmaceuticals PLC
18/08/202307:06Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:RVLPRVL Pharmaceuticals PLC
18/08/202307:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVLPRVL Pharmaceuticals PLC
18/08/202306:05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:RVLPRVL Pharmaceuticals PLC
16/08/202322:00GlobeNewswire Inc.RVL Pharmaceuticals plc Announces $5 Million Registered Direct Offering Priced At-the-Market under Nasdaq RulesNASDAQ:RVLPRVL Pharmaceuticals PLC
 Showing the most relevant articles for your search:NASDAQ:RVLP